[Yeouido Investment Division 1] Seers, Inzenia Therapeutics: which stock will enter the Hall of Fame?
Predicted impact: Low
Market commentary piece with no new company facts.
Seers씨어스
458870 · KOSDAQ · ₩458870 · 씨어스
₩24,600▼ ₩1,700 (6.46%)End-of-day · Oct 28, 2026 · End-of-day prices.
Seers expands from Southeast Asia to Central Asia, introduces AI smart ward in Kazakhstan
Predicted impact: Low
Overseas expansion demonstration of AI smart ward; no size given.
[BioS] Seers introduces AI medical solution to Kazakhstan's Ministry of Health
Predicted impact: Low
Introducing AI medical solution to a foreign health ministry is an early-stage, small-impact update.
Daewoong Pharma Supplies Seers' AI Monitoring System 'Think' to 342 Beds at Ajou University Hospital
Predicted impact: Low
Same Ajou University Hospital supply news as the other item; small relative to revenue
[BioS] Seers Technology Opens New Yongin Plant, Wearable Patch Capacity Up "1.6x"
Predicted impact: Low
New plant opening with 1.6x capacity; no financial size given.
[The Bell] Cerus Completes ₩110B Fundraising, Full-Scale US and Middle East Investment Begins
High impactPredicted impact: High
₩110B fundraising is about 12.6% of ₩874B market value, likely via new shares.
[The Bell] Seers begins AI arrhythmia screening demonstration in UAE; IRB approval obtained
Predicted impact: Low· Actual: +10.1% vs sector, volume 1.4× normal (5 trading days)
UAE IRB approval and demonstration start were already reported; small company, no size given.
Seers to Begin Nationwide AI Arrhythmia Screening in UAE, Final Testing Underway
Predicted impact: Low· Actual: +10.1% vs sector, volume 1.4× normal (5 trading days)
UAE national screening is only in final testing; no contract value disclosed.
[BioS] Seers Receives IRB Approval from Abu Dhabi Department of Health for AI Arrhythmia Product
Predicted impact: Low· Actual: +10.1% vs sector, volume 1.4× normal (5 trading days)
Ethics board approval for a study in Abu Dhabi; an early step, not a contract.
National Growth Fund also draws interest… Seers Technology sets new benchmark for medical AI's US expansion
Predicted impact: Medium· Actual: −1.0% vs sector, volume 1.8× normal (5 trading days)
KRW 110B convertible bonds, about 12% of market value, repeat of earlier recent issuance news.
Seers Technology's 'One-Strong Position' Wobbles…Wearable ECG Market in Turmoil
Predicted impact: Medium· Actual: −1.0% vs sector, volume 1.8× normal (5 trading days)
₩110B convertible bonds are about 12% of market value; repeated across recent filings, so lowered one level.
Seers Technology to Issue ₩110B Convertible Bonds… "Targeting U.S. AI Diagnostics Market"
Predicted impact: Medium· Actual: +1.5% vs sector, volume 2.0× normal (5 trading days)
₩110B convertible bond, about 12% of market value; repeats the board approval already reported.
[BioS] Thears Sets Board Approval for ₩110B Convertible Bond Issuance; ₩70B to Be Invested Overseas
Predicted impact: Medium· Actual: +1.5% vs sector, volume 2.0× normal (5 trading days)
₩110B convertible bond, about 12% of ₩920B market value; large relative to size.
Also known as: Seers / 씨어스 / 458870 / KRX:458870
Source: KRX statistical information